2Seventy Bio Inc
NASDAQ:TSVT

Watchlist Manager
2Seventy Bio Inc Logo
2Seventy Bio Inc
NASDAQ:TSVT
Watchlist
Price: 3.05 USD -0.33% Market Closed
Market Cap: 157.3m USD
Have any thoughts about
2Seventy Bio Inc?
Write Note

P/E
Price to Earnings

-1.7
Current
-1.9
Median
21.6
Industry
Higher than median
Lower than industry value

Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.

P/E
-1.7
=
Market Cap
157.1m USD
/
Net Income
-94.5m USD
All Countries
Close
Market Cap P/E
US
2Seventy Bio Inc
NASDAQ:TSVT
157.1m USD -1.7
FR
Pharnext SCA
OTC:PNEXF
6T USD -180 872.1
US
Abbvie Inc
NYSE:ABBV
314.6B USD 61.9
US
Amgen Inc
NASDAQ:AMGN
141.2B USD 33.4
US
Gilead Sciences Inc
NASDAQ:GILD
117.3B USD 930.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
105.4B USD -219.6
US
Epizyme Inc
F:EPE
94.1B EUR -472.4
AU
CSL Ltd
ASX:CSL
136.4B AUD 32.1
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
78.4B USD 16.9
US
Seagen Inc
F:SGT
39.3B EUR -54.7
NL
argenx SE
XBRU:ARGX
36.2B EUR -136.2
Earnings Growth PEG
US
2Seventy Bio Inc
NASDAQ:TSVT
Average P/E: 215
Negative Multiple: -1.7
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -180 872.1 N/A N/A
US
Abbvie Inc
NYSE:ABBV
61.9
72%
0.9
US
Amgen Inc
NASDAQ:AMGN
33.4
20%
1.7
US
Gilead Sciences Inc
NASDAQ:GILD
930.6
21%
44.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -219.6
14%
N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -472.4 N/A N/A
AU
CSL Ltd
ASX:CSL
32.1
18%
1.8
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.9
13%
1.3
US
S
Seagen Inc
F:SGT
Negative Multiple: -54.7 N/A N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -136.2 N/A N/A

P/E Forward Multiples

Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/E
-3.1
2-Years Forward
P/E
-5.9
3-Years Forward
P/E
-14.6

See Also

Discover More